Recombinant Human CD25/IL-2 R alpha Protein Summary
Recombinant Protein
IL2RA
Applications/Dilutions
In Vitro Wheat Germ System + Liposome Technology offers significant advantages over commonly used protein expression platforms:
Higher Yield
Greater Stability
High Expression Success Rate
Native Protein Conformation
This protein has not yet been tested for use in functional studies and/or compound screening.
All experiments requiring biological activity of the protein will not be backed by the Novus Guarantee or be eligible for the Innovators Reward™ and must be undertaken at the customers own risk.
Packaging, Storage & Formulations
Store at -80C. Avoid freeze-thaw cycles.
25 mM Tris-HCl of pH8.0 containing 2% glycerol.
No Preservative
Notes
This product is produced by and distributed for Abnova, a company based in Taiwan.
Alternate Names for Recombinant Human CD25/IL-2 R alpha Protein
- CD25 antigen
- CD25
- IDDM10
- IL-2 R alpha
- IL-2 receptor subunit alpha
- IL2R alpha
- IL-2R subunit alpha
- IL2R
- IL2RA
- IL-2Ra
- IL-2-RA
- IL2-RA
- interleukin 2 receptor, alpha
- interleukin-2 receptor subunit alpha
- p55
- TAC antigen
- TCGFR
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.
product targets : HIF_HIF Prolyl-Hydroxylase inhibitors